BREAST CANCER TRIPLE NEGATIVE
Clinical trials for BREAST CANCER TRIPLE NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER TRIPLE NEGATIVE trials appear
Sign up with your email to follow new studies for BREAST CANCER TRIPLE NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to boost breast cancer treatment before chemo
Disease control Recruiting nowThis study tests a new approach for people with stage 2 or 3 breast cancer. Before standard chemotherapy, participants receive targeted radiation and an immunotherapy drug (pembrolizumab) injected into the tumor. The goal is to see if this combination can improve the chance of el…
Matched conditions: BREAST CANCER TRIPLE NEGATIVE
Phase: PHASE2 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated May 26, 2026 02:23 UTC
-
New study tracks immune signals in breast cancer patients
Knowledge-focused Recruiting nowThis study looks at how the immune system responds in people with early-stage triple negative breast cancer who are receiving standard chemotherapy combined with immunotherapy (pembrolizumab). Researchers will measure certain immune markers in the blood and tumor tissue to see if…
Matched conditions: BREAST CANCER TRIPLE NEGATIVE
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 26, 2026 02:21 UTC